After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...

Neoantigen-targeting personalized cancer vaccines (PCVs) are highly immunogenic in high-risk clear cell renal cell ca ...

In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping ...

“The key to preventing cervical cancer is identifying high-risk HPV strains early and taking action before any harm is done. This is why the HPV vaccine and routine screening are critical ...

Advances in mammography saved a significant number of lives, as did human papillomavirus (HPV) vaccines in the case of cervical cancer and removal of precancerous polyps in the case of colorectal ...

In a nutshell Researchers developed personalized cancer vaccines for nine high-risk kidney cancer patients, with all participants remaining cancer-free after nearly three years of follow-up – a ...